Welcome, MedTech Gurus! Today, we dive into the complex world of artificial intelligence in healthcare with Dr. Jay Anders, Chief Medical Officer at Medicomp Systems. Dr. Anders shares his unique journey from practicing medicine to pioneering AI solutions that prioritize patient safety, transparency, and high-quality data. Medicomp Systems is breaking ground by integrating AI responsibly at the point of care, focusing on tools clinicians can rely on while treating patients. Join us as Dr. Anders discusses the ethical challenges, the importance of real-world data, and best practices for entrepreneurs looking to  innovate responsibly in the medtech space. This is an episode you don’t want to miss!

Welcome to Med Tech Gurus!

In this episode, we’re joined by Ricardo Roman, Chief Sales Officer at Fracttal, who brings a wealth of experience in optimizing healthcare operations through asset management and maintenance technology. Ricardo shares insights on how strategic asset management can drive better service quality and operational performance, directly impacting patient care.

With his background mentoring startups and working with major healthcare providers, Ricardo dives into the challenges of innovating in the healthcare sector, especially in regions with limited resources. He discusses the importance of understanding the full lifecycle of medical assets, highlighting how technologies like IoT and AI are revolutionizing maintenance practices by enabling more efficient resource allocation and predictive maintenance.

Ricardo also provides actionable advice for healthcare leaders on integrating data systems to optimize decision-making and improve overall performance. Tune in to learn how Fracttal is advancing the industry, the benefits of a circular economy approach, and best practices for scaling technology solutions in healthcare.

Don't miss this episode packed with insights on enhancing healthcare through smarter asset management and technological innovation.

Welcome to Med Tech Gurus!

In today’s exciting episode, we are joined by Alan D. Roth, the Chief Executive at Oxford Drug Design. Alan and his team are at the forefront of leveraging artificial intelligence to revolutionize drug discovery, addressing some of the most pressing healthcare challenges, including antibiotic resistance and cancer treatment. With deep expertise in computational chemistry, Oxford Drug Design has successfully built a platform that accelerates drug development by predicting, designing, and optimizing molecules that can be produced at scale and perform effectively in real-world clinical settings.

In this conversation, Alan shares the key innovations driving their Synth AI platform, which goes beyond theory to deliver viable drug candidates. We’ll explore how Oxford Drug Design’s platform not only identifies potent molecules but also ensures they can be manufactured cost-effectively and with clean safety profiles. Alan also discusses the importance of fostering innovation, balancing focus with creativity, and raising capital in the life sciences space.

This episode provides a fascinating deep dive into AI’s impact on drug discovery and offers invaluable advice for entrepreneurs looking to navigate the complex world of healthcare technology.

Get ready for an insightful and inspiring discussion about the future of AI in healthcare with Alan Roth—this is one you don’t want to miss!

Welcome to Med Tech Gurus!

In today’s episode, we are excited to host two exceptional guests: John Dugas and Abbi Johnson from Solventum. Formerly part of 3M, Solventum has become a leading force in the healthcare industry, focusing on innovative medical adhesives. John serves as the Global Business Leader, leveraging decades of expertise to drive advancements in product development and patient safety. Abbi, a Product Development Engineer, plays a critical role in transforming prototypes into market-ready solutions, ensuring high performance and patient comfort.

This episode dives into Solventum’s transition from 3M, exploring how a singular focus on healthcare has opened new doors for collaboration and innovation. John and Abbi share their journey of creating cutting-edge adhesives like the new 2487 high-tac silicone tape, which combines strong adhesion with gentle application, breaking the industry myth that performance must come at the cost of comfort.

You’ll also hear insights into the challenges of scaling medical technologies globally, Solventum’s commitment to patient-centered design, and the trends shaping the future of medical wearables and adhesives for sensitive skin.

Get ready for an engaging conversation packed with practical advice and forward-thinking ideas that will inspire anyone working at the intersection of healthcare and technology. This is an episode you won’t want to miss!

Welcome to Med Tech Gurus!

In this exciting episode, we are joined by Gary Warren, CEO of IV Watch. With over 14 years at the helm of IV Watch, Gary has led the charge in revolutionizing IV therapy safety, with the company securing 69 patents and achieving widespread use in hospitals worldwide, including some of the top children's hospitals in the U.S. IV Watch’s innovative biosensor technology continuously monitors IV sites to detect leaks and prevent injuries, ensuring medication flows safely into the vein. This game-changing technology has drastically improved patient outcomes by minimizing the risk of infiltration and extravasation.

Gary brings a fascinating background as a former NASA research scientist and software security expert. In this episode, he shares the journey of building IV Watch, from early experiments in his basement to working with world-class children's hospitals, and how his team developed cutting-edge sensors capable of performing 18,000 checks per hour.

We’ll explore the challenges of building medical technology, the importance of continuous monitoring in IV therapy, and Gary’s insights into navigating the complex world of regulatory approvals. Plus, you’ll hear real-world stories from critical care settings, where IV Watch has made a profound impact.

Get ready for a deep dive into patient safety, innovation, and entrepreneurship as Gary Warren walks us through his incredible journey. This is a conversation packed with insights, inspiring breakthroughs, and practical advice for anyone passionate about improving healthcare outcomes.

Welcome to Med Tech Gurus!

In this episode, we are thrilled to have Costin Tuculescu, CEO of Onscreen, with us. Costin is a serial entrepreneur and expert in video conferencing who is using his expertise to make a remarkable impact in the senior care space. At Onscreen, his team is leveraging AI-powered, TV-based caregiving technology to combat loneliness, isolation, and even cognitive decline among seniors.

Costin shares his inspiring journey, from building innovative video solutions to launching a product that reimagines how seniors stay connected with their loved ones and caregivers. We’ll dive deep into the health risks associated with loneliness, how Onscreen simplifies telehealth interactions, and the revolutionary role of AI in enhancing well-being.

Join us as we explore how Costin's team is turning every TV into a caregiving platform, transforming the lives of aging adults, and breaking new ground in healthcare innovation.

Get ready for a fascinating conversation packed with valuable insights, innovative technology, and inspiring solutions from a leader who’s at the forefront of senior care!

Welcome to Med Tech Gurus!

Today, we have two exceptional guests who are revolutionizing the field of bariatric surgery. First, we have Dr. Jon L. Schram, Section Chief and Medical Director of Bariatric Surgery at Corewell Health. With a distinguished career, Dr. Schramm has been pivotal in advancing surgical techniques and improving patient outcomes. He is also a lead author on a recent study published in Obesity Surgery, showcasing the clinical benefits of the Titan SGS stapler.

Joining him is James Ferguson, President and General Manager, Surgical at Teleflex. James has a robust background in medical device innovation and played a key role in developing and commercializing the Titan SGS stapler. His career spans multiple leadership roles, where he has driven product innovation, market expansion, and operational excellence in the med tech sector.

In this episode, we’ll dive into the evolution of gastric sleeve surgery, explore how the Titan SGS stapler is setting new standards in bariatric surgery, and discuss the impact of GLP-1 drugs on clinical practices. Get ready for a fascinating conversation filled with cutting-edge insights and practical takeaways from two leaders at the forefront of surgical innovation!

Welcome to Med Tech Gurus!

Today, we have an exceptional guest with us—Daniel Powell, CEO and co-founder of Spark Biomedical. Spark Biomedical is pioneering wearable neurostimulation technology with a mission to provide drug-free, non-invasive solutions for challenging conditions such as opioid withdrawal and addiction recovery.

With over 25 years of experience delivering innovative technical solutions across various industries, Daniel has led Spark Biomedical in developing the FDA-cleared Sparrow Ascent, a revolutionary device that helps patients manage opioid withdrawal symptoms effectively and comfortably.

In this episode, Daniel shares the inspiring story behind Spark Biomedical, the science and innovation driving their breakthrough technology, and the challenges they overcame to bring it to market. He also offers valuable insights into securing funding, navigating regulatory hurdles, and the importance of storytelling in pitching to investors.

Get ready to dive into a compelling conversation filled with innovation, perseverance, and impactful solutions for one of today's most pressing health crises.

Today, we’re excited to welcome Brian Hilberdink, Executive Vice President of North America and President of Leo Pharma, Inc. With over 26 years of experience at Novo Nordisk, Brian’s journey from managing theme parks to shaping the future of medical dermatology is truly inspiring.

In this episode, Brian shares the critical role of fostering cross-organizational alignment and the importance of transitioning from traditional R&D to "Search and Development" to address unmet needs in medical dermatology. He also discusses Leo Pharma’s strategy of "putting pearls on a string" to build a portfolio of value-driven assets and his experience in navigating cultural differences when working with global teams.

Get ready for a captivating conversation filled with practical advice and leadership insights!

Welcome, Med Tech Gurus!

Today, we’re excited to have Brent Ness, CEO of Aclarion, with us. Brent, a seasoned medtech leader with experience at companies like GE Healthcare and Medtronic, is now guiding Aclarion's mission to transform the diagnosis of chronic low back pain.

Aclarion’s Nociscan technology uses MRI scans to identify chemical biomarkers in spinal discs, helping doctors pinpoint pain sources that traditional imaging often misses. Under Brent’s leadership, Aclarion has achieved major milestones, including partnerships with key opinion leaders and securing insurance coverage in the UK.

You will enjoy this episode as Brent shares valuable lessons and insights about commercializing disruptive technology and navigating the healthcare landscape.